These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23936092)

  • 21. Structural insights into chondroitin sulfate binding in pregnancy-associated malaria.
    Khunrae P; Higgins MK
    Biochem Soc Trans; 2010 Oct; 38(5):1337-41. PubMed ID: 20863310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.
    Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW
    Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
    Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ
    J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.
    Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N
    J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies.
    Avril M; Gamain B; Lépolard C; Viaud N; Scherf A; Gysin J
    Microbes Infect; 2006; 8(14-15):2863-71. PubMed ID: 17095277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
    Avril M; Hathaway MJ; Srivastava A; Dechavanne S; Hommel M; Beeson JG; Smith JD; Gamain B
    PLoS One; 2011 Feb; 6(2):e16622. PubMed ID: 21326877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding.
    Wang K; Dagil R; Lavstsen T; Misra SK; Spliid CB; Wang Y; Gustavsson T; Sandoval DR; Vidal-Calvo EE; Choudhary S; Agerbaek MØ; Lindorff-Larsen K; Nielsen MA; Theander TG; Sharp JS; Clausen TM; Gourdon P; Salanti A
    Nat Commun; 2021 May; 12(1):2956. PubMed ID: 34011972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disulfide bond and crosslinking analyses reveal inter-domain interactions that contribute to the rigidity of placental malaria VAR2CSA structure and formation of CSA binding channel.
    Jagadeeshaprasad MG; Gautam L; Bewley MC; Goel S; Akhouri RR; Gowda DC
    Int J Biol Macromol; 2023 Jan; 226():143-158. PubMed ID: 36470436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates.
    Lekana Douki JB; Traore B; Costa FT; Fusaï T; Pouvelle B; Sterkers Y; Scherf A; Gysin J
    Blood; 2002 Aug; 100(4):1478-83. PubMed ID: 12149234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.
    Fernandez P; Petres S; Mécheri S; Gysin J; Scherf A
    PLoS One; 2010 Sep; 5(9):e12558. PubMed ID: 20838433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
    Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF
    Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.
    Barfod L; Dalgaard MB; Pleman ST; Ofori MF; Pleass RJ; Hviid L
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12485-90. PubMed ID: 21746929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies.
    Khunrae P; Dahlbäck M; Nielsen MA; Andersen G; Ditlev SB; Resende M; Pinto VV; Theander TG; Higgins MK; Salanti A
    J Mol Biol; 2010 Apr; 397(3):826-34. PubMed ID: 20109466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overproduction, purification and crystallization of a chondroitin sulfate A-binding DBL domain from a Plasmodium falciparum var2csa-encoded PfEMP1 protein.
    Higgins MK
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Mar; 64(Pt 3):221-3. PubMed ID: 18323614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
    Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
    Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.
    Sugiura N; Clausen TM; Shioiri T; Gustavsson T; Watanabe H; Salanti A
    Glycoconj J; 2016 Dec; 33(6):985-994. PubMed ID: 27287227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a 67-amino-acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates.
    Gamain B; Smith JD; Avril M; Baruch DI; Scherf A; Gysin J; Miller LH
    Mol Microbiol; 2004 Jul; 53(2):445-55. PubMed ID: 15228526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.